Intercontinental Wealth Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-14,257
| Closed | -$318K | – | 266 |
|
|
2022
Q2 | $318K | Hold |
14,257
| – | – | 0.09% | 218 |
|
|
2022
Q1 | $358K | Sell |
14,257
-730
| -5% | -$18.3K | 0.08% | 216 |
|
|
2021
Q4 | $537K | Sell |
14,987
-188
| -1% | -$6.74K | 0.11% | 173 |
|
|
2021
Q3 | $646K | Sell |
15,175
-759
| -5% | -$32.3K | 0.15% | 137 |
|
|
2021
Q2 | $690K | Buy |
15,934
+88
| +0.6% | +$3.81K | 0.14% | 125 |
|
|
2021
Q1 | $646K | Buy |
15,846
+239
| +2% | +$9.74K | 0.14% | 125 |
|
|
2020
Q4 | $706K | Buy |
15,607
+77
| +0.5% | +$3.48K | 0.17% | 111 |
|
|
2020
Q3 | $550K | Buy |
15,530
+308
| +2% | +$10.9K | 0.16% | 106 |
|
|
2020
Q2 | $574K | Buy |
15,222
+2,754
| +22% | +$104K | 0.19% | 95 |
|
|
2020
Q1 | $360K | Buy |
+12,468
| New | +$360K | 0.19% | 103 |
|